SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Matthew Wecksell who wrote (1564)5/20/1998 8:46:00 PM
From: Bob L  Read Replies (1) of 1762
 
I said after learning the risks. I didn't say anything about just "tossing" drugs in. Maurice's and my conversation goes back to some previous posts about the difficulties posed when a well informed person might rationally choose to use a drug that is in phase III or off-label use of an approved drug like Rituxan.

And don't "bub" me, Mr. Medical Student. Unless you are a very slow student, it appears I was doing research in medical malpractice when you were still learning to read. You may not realize how much control has shifted from doctors to patients in the last 20 years. But there is still a ways to go.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News